Product Information

AMITRIPTYLINE HCL 10 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0375 per EA under NDC 16729017117. Its NADAC has been published 526 times since Feb 11, 2015.

The High Outlier badge above means this manufacturer's average price in the AMITRIPTYLINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AMITRIPTYLINE HCL 10 MG TAB

AMITRIPTYLINE HYDROCHLORIDE
$0.0375per EA
High Outlier

Strength

10 mg/1

NDC

16729017117

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/19/2025

Active Ingredients

AMITRIPTYLINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202446

On Market Since

12/5/2014

Pharmacological Classes

Price Statistics

The NADAC for AMITRIPTYLINE HCL 10 MG TAB has been published 526 times since Feb 11, 2015, and over the history we have for it it has declined 71.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0375 per EA
All-time high$0.1311 (Feb 11, 2015)
All-time low$0.0285 (Nov 20, 2024)
Median price$0.0728
Average price$0.0777
Largest weekly change+30.2% (Jun 19, 2024)
Weeks tracked526
Tracking sinceFeb 11, 2015

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-11.0%

5Y

-36.9%

All

-71.4%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 15%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of AMITRIPTYLINE HCL 10 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 10 MG TAB, manufactured by Accord Healthcare Inc., is $0.0375 per EA (NDC 16729017117), effective Mar 5, 2025.

How has the price of AMITRIPTYLINE HCL 10 MG TAB changed over time?

Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 10 MG TAB has declined 71.4%. It has been tracked across 526 weekly CMS publications since Feb 11, 2015.

What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 10 MG TAB?

Since Feb 11, 2015, the NADAC for AMITRIPTYLINE HCL 10 MG TAB has ranged from a low of $0.0285 (Nov 20, 2024) to a high of $0.1311 (Feb 11, 2015), with a median of $0.0728 per EA.

Are there cheaper alternatives to AMITRIPTYLINE HCL 10 MG TAB?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, AMITRIPTYLINE HCL 10 MG TAB, is $0.0320 per EA — about 15% below AMITRIPTYLINE HCL 10 MG TAB.

Who manufactures AMITRIPTYLINE HCL 10 MG TAB?

AMITRIPTYLINE HCL 10 MG TAB (NDC 16729017117) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.